Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
07/2014
07/10/2014US20140193335 Devices and methods for the treatment of cancer
07/10/2014US20140193334 Targeted Delivery and Prodrug Designs for Platinum-Acridine Anti-Cancer Compounds and Methods Thereof
07/10/2014US20140193329 Anti-cd151 antibodies and their use in the treatment of cancer
07/09/2014EP2752201A1 C-terminal HSP90 inhibitors to treat pituitary adenomas
07/09/2014EP2752198A1 Vaccine preparation for cancer treatment
07/09/2014EP2752190A1 Method for improving therapy for autoimmune diseases such as rheumatoid arthritis
07/09/2014EP2752189A1 Use of anti-vegf antibody in combination with chemotherapy for treating breast cancer
07/09/2014EP2750710A1 Use of compositions having a low polyamine content in the prevention or treatment of adverse effects linked to cancer treatment
07/09/2014EP2750675A1 Synergistic combinations of pi3k- and mek-inhibitors
07/09/2014DE202014101773U1 Struktur der spezifischen Antidote mit allopathischen Heilmitteln in der Außenverpackung Structure of specific antidotes with allopathic remedies in the outer packaging
07/09/2014CN103917659A Etfb在细胞异常增殖中的应用方法以及异常增殖抑制剂 Etfb in abnormal cell proliferation and abnormal proliferation inhibitor application methods
07/09/2014CN103917248A 肠纤维化处理剂 Intestinal fibrosis treatment agent
07/09/2014CN103908670A 一种治疗畜禽大肠杆菌感染疾病的复方组合物 A treatment of E. coli infections in poultry compound composition
07/09/2014CN103432596B 新癀片中药成分镇痛作用的机理研究方法 Analgesic effect of Chinese medicine mechanism Xinhuang Tablets research methods
07/09/2014CN102805867B 转录因子nfatc3作为药物靶点在逆转肿瘤多药耐药中的应用 Nfatc3 as drug targets the transcription factor used in the reversal of multidrug resistance
07/09/2014CN102266302B 旨在避免非主观误服和非法滥服的抗张性片剂 Designed to avoid the reach of non-subjective and illegal Lanfu tensile tablets
07/09/2014CN101653603B 磷脂酰乙醇胺结合肽缀合物及其治疗病毒感染的用途 Phosphatidylethanolamine binding peptide conjugates and their use to treat viral infections
07/09/2014CN101378730B 含有水不溶性无机磷酸盐结合剂的粒状物质 Containing a water-insoluble inorganic phosphate binder particulate material
07/08/2014US8774885 Device for generating a detectable signal based upon concentration of at least one substance
07/08/2014US8772336 Cathepsin cysteine protease inhibitors
07/08/2014US8772335 Adamantyl derivatives as therapeutic agents
07/08/2014US8772328 Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
07/08/2014US8772263 Methods and compositions for protecting or treating muscarinic receptors through administration of pyrophosphate analog in subjects exposed to toxic or carcinogenic metals or metal ions
07/08/2014US8772252 Coumarin compounds as melanogenesis modifiers and uses thereof
07/08/2014US8772242 Therapy for enteric infections
07/08/2014US8771973 Methods for treating bleeding disorders using sulfated polysaccharides
07/08/2014US8771731 Antimicrobial nanoemulsion compositions and methods
07/08/2014US8771727 Microfluidized oil-in-water emulsions and vaccine compositions
07/08/2014US8771696 Method of reducing the severity of stress hyperglycemia with human antibodies to the glucagon receptor
07/08/2014US8771681 Methods and compositions for protecting and treating muscarinic receptors by administering a pyrophosphate analog to a subject exposed to bacterial, fungal, viral, prion or algal infection
07/08/2014CA2819705C Method of regulating glucose metabolism, and reagents related thereto
07/08/2014CA2737879C Single unit carbapenem aminoglycoside formulations
07/08/2014CA2682391C (aza)indole derivative and use thereof for medical purposes
07/08/2014CA2650341C Augmentation of titer for vaccination in animals
07/08/2014CA2609617C Feline probiotic lactobacilli
07/08/2014CA2604052C Methods and compositions for the treatment of cns-related conditions
07/08/2014CA2524891C Ultraviolet-shielding type patch
07/08/2014CA2514659C New strains of bifidobacterium having the ability to produce glutamine
07/08/2014CA2469370C Adipose-derived cell processing unit
07/08/2014CA2431800C Peptide yy and peptide yy agonists for treatment of metabolic disorders
07/08/2014CA2417568C Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
07/03/2014WO2014105966A2 Ddr2 mutations as targetable features of melanoma or basal cell carcinoma
07/03/2014WO2014104406A1 Therapeutic agent for osteoporosis and method for screening therapeutic agent
07/03/2014WO2014104279A1 SUBSTITUTED SPIROPYRIDO[1,2-a]PYRAZINE DERIVATIVE AND MEDICINAL USE THEREOF AS HIV INTEGRASE INHIBITOR
07/03/2014WO2014104224A1 PGC-1β-PROTEIN-FUNCTION REGULATOR, MITOCHONDRIA-FUNCTION REGULATOR, ANTI-OBESITY AGENT, AND SCREENING METHOD THEREFOR
07/03/2014WO2014104149A1 Preparation for application to skin
07/03/2014WO2014102693A1 Pharmaceutical composition containing a derivative of n-phenylpyrazole and permethrin, and use for the production of a topical veterinary medicament
07/03/2014WO2014102312A2 Minimally toxic prodrugs
07/03/2014WO2014041088A3 Combined treatment with netrin-1 interfering drug and chemotherapeutic drug
07/03/2014US20140187772 Pyrazole compounds useful as protein kinase inhibitors
07/03/2014US20140187641 Estrogen receptor ligands and methods of use thereof
07/03/2014US20140187597 Pharmaceutical compositions for the treatment of movement disorders
07/03/2014US20140187554 Modulators of the nuclear hormone receptor ror
07/03/2014US20140187551 7-azaindole derivatives suitable for treatment of cancers
07/03/2014US20140187524 Treatment of Depressive Disorders
07/03/2014US20140187516 Dosage regimen of an s1p receptor modulator
07/03/2014US20140187494 Inhibition of inflammation using antagonists of muc1
07/03/2014US20140187476 Peptide derivative fusion inhibitors of hiv infection
07/03/2014US20140187470 Agonists of Guanylate Cyclase Useful For the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
07/03/2014US20140187441 Amplification of cyp24 and uses thereof
07/03/2014US20140186471 Composition for inhibition of cathepsin k
07/03/2014US20140186469 Pyrrolidine-1,2-dicarboxamide derivatives
07/03/2014US20140186464 Prophylactic agent and/or therapeutic agent for sepsis
07/03/2014US20140186438 Compositions comprising epa and obeticholic acid and methods of use thereof
07/03/2014US20140186416 Method for repairing or replacing damaged tissue
07/03/2014US20140186407 C-Met Modulator Pharmaceutical Compositions
07/03/2014US20140186404 Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione in combination with antibodies
07/03/2014US20140186400 Methods and compositions for treating autoimmune diseases
07/03/2014US20140186367 Methods and compositions related to glucocorticoid receptor antagonists and breast cancer
07/03/2014US20140186362 Anti-Interferon Gamma Antibodies And Methods Of Use Thereof
07/03/2014US20140186359 Pharmaceutical composition for treatment and/or prophylaxis of cancer
07/03/2014US20140186347 Extending time to disease progression or survival in cancer patients
07/03/2014US20140186345 Method of administering an antibody
07/03/2014US20140186335 Certain Compounds, Compositions and Methods
07/03/2014US20140186329 Polyphenol analogs to treat ischemia
07/03/2014US20140186328 Neuroprotective polyphenol analogs
07/03/2014US20140186312 Method Comprising Contacting Tissue With a Cross-Linkable Polyester Prepolymer
07/03/2014US20140186306 Novel ampk agonist compositions and methods of use
07/03/2014US20140186301 Reoviruses having modified sequences
07/03/2014US20140186299 Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
07/03/2014US20140186288 Co-Therapy for Diabetic Conditions
07/03/2014US20140186266 Conjugates of nitroimidazoles and their use as chemotherapeutic agents
07/02/2014EP2749292A1 Tumor chemotherapeutic drug formulation and preparation method thereof
07/02/2014EP2749285A1 Osteogenesis promoter and use thereof
07/02/2014EP2749281A1 Prophylactic/therapeutic agent for cardiovascular complications of diabetes
07/02/2014CN203677566U 一种用于治疗幽门螺杆菌的双层片 A double-layer tablets for the treatment of Helicobacter pylori
07/02/2014CN103906522A 阿片激动剂化合物和止痛化合物的组合物、剂型以及共给药 Opioid agonist analgesic compounds and compositions of the compounds, the dosage form, and co-administration
07/02/2014CN103906516A 用于增强T细胞介导的免疫应答的β-内酰胺化合物 Β- lactam compounds for enhancing the immune response of T cell-mediated
07/02/2014CN103906515A 治疗黏液表皮样癌的方法 Mucoepidermoid cancer treatment method
07/02/2014CN103898190A Toll作用蛋白（Tollip）基因在冠状动脉粥样硬化性心脏病中的应用 Toll role of protein (Tollip) gene in coronary artery atherosclerotic heart disease
07/02/2014CN103898189A 信号调节蛋白α（SHPS-1）基因在冠状动脉粥样硬化性心脏病中的应用 Signal-regulated protein α (SHPS-1) gene in coronary artery atherosclerotic heart disease
07/02/2014CN103897032A 一种新型细胞穿膜肽 A novel cell-penetrating peptides
07/02/2014CN103893775A 亲水性组合物及含有该组合物的巴布剂 The hydrophilic composition and the cataplasm containing the composition
07/02/2014CN103893763A Vinexin-β基因在冠状动脉粥样硬化性心脏病中的应用 Vinexin-β gene in coronary artery atherosclerotic heart disease
07/02/2014CN103893762A 一种急性粒细胞白血病治疗靶标及其用途 An acute myeloid leukemia therapeutic targets and their use
07/02/2014CN103893409A 一种瑞香狼毒提取物贴剂 One kind of patch extract Stellera chamaejasme
07/02/2014CN103893403A 一种瑞香狼毒组分 One kind of component Stellera chamaejasme
07/02/2014CN103893401A 一种瑞香狼毒组分薄膜衣片 One kind of film-coated tablets Stellera chamaejasme component
07/02/2014CN103893400A 一种瑞香狼毒提取物肠溶片 One kind Stellera chamaejasme extract enteric-coated tablets
07/02/2014CN103893399A 一种瑞香狼毒提取物干混悬剂 One kind Stellera chamaejasme extract dry suspension
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 1151